文献速递角膜与眼表疾病

微生物性角膜炎评估与治疗综合临床算法的验证

Validation of a Comprehensive Clinical Algorithm for the Assessment and Treatment of Microbial Keratitis.
PubMed 文献 · Am J Ophthalmol · 2019-12-30

该回顾性队列研究比较了麻省眼耳医院在实施「1,2,3规则」算法前后微生物性角膜炎患者的结局,发现算法整体未显著减少视力威胁并发症,但仅满足1项标准者并发症比例从9.7%降至1.8%,且不必要培养减少。

要点

  • 「1,2,3规则」要求满足前房细胞≥1+、浸润≥2mm或距角膜中心≤3mm之一时行角膜培养并用强化抗生素。
  • 仅满足1项标准的患者接受算法管理后视力威胁并发症从9.7%降至1.8%。
  • 算法实施后不符合任何标准仍行培养的比例从23.9%降至8.5%。

核心结论

  • 实施该算法减少了仅满足1项标准的患者发生视力威胁并发症的风险。
  • 算法实施还减少了接受不必要诊疗的患者比例。

研究设计与样本

  • 回顾性队列研究,比较算法实施前2年(Group I,n=665)与实施后(Group II,n=767)就诊于麻省眼耳医院的微生物性角膜炎病例。

主要发现

  • 中位随访67.0天和60.0天时,172例患者发生视力威胁并发症,Group I为12.9%,Group II为11.2%(P=.51)。
  • 仅满足1项标准的患者中,就诊时培养比例从54.6%升至67.7%(P=.006),强化抗生素处方比例从29.7%升至53.9%(P<.001),视力威胁并发症从9.7%降至1.8%(P=.001)。
  • 就诊时未培养但后续需培养的比例从13.4%降至5.1%(P=.001),不符合任何标准仍行培养的比例从23.9%降至8.5%(P<.001)。
  • 多因素logistic回归显示前房细胞≥1+(OR 1.66,95%CI 1.09-2.52)、浸润≥2mm(OR 4.74,2.68-8.40)、距角膜中心≤3mm(OR 2.82,1.85-4.31)均与结局独立相关。

关键数值与推荐

  • 「1,2,3规则」:满足前房细胞≥1+、浸润≥2mm或浸润距角膜中心≤3mm中任一条件时,行角膜培养并强制使用强化局部抗生素。

临床怎么用

  • 对仅满足1项标准的微生物性角膜炎患者,按算法行角膜培养并启用强化抗生素可降低视力威胁并发症。
  • 算法有助于减少不符合标准患者的不必要培养和诊疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To validate a comprehensive clinical algorithm for the assessment and treatment of microbial keratitis (MK). DESIGN: Retrospective cohort study. METHODS: The "1, 2, 3 Rule" for the initial management of MK was conceived by Vital and associates in 2007 to inform the decision as to when to perform corneal cultures. The rule is invoked when any 1 of 3 clinical parameters is met: ≥1+ anterior chamber cells, ≥2 mm infiltrate, or infiltrate ≤3 mm distance from the corneal center. When the rule is met, we added the mandatory use of fortified topical antibiotics after cultures are obtained. We compared outcomes of cases presenting to Massachusetts Eye and Ear 2 years before (Group I, n = 665) and after (Group II, n = 767) algorithm implementation. The primary composite outcome was a vision-threatening complication, such as corneal perforation. RESULTS: At a median follow-up of 67.0 and 60.0 days, respectively, 172 patients experienced a vision-threatening complication (Group I, 12.9% vs Group II, 11.2%, P = .51). While the algorithm codified conventional management practice at either end of disease severity, the effect of algorithm-augmented care was best appreciated in patients with lesions satisfying only 1 criterion. In this group, there was an increase in the proportion of patients undergoing culture at presentation (54.6% vs 67.7%, P = .006), fortified antibiotic prescription (29.7% vs 53.9%, P < .001), and reduction in vision-threatening complications (9.7% vs 1.8%, P = .001). The proportion of patients who were not cultured at presentation but later required culturing decreased (13.4% vs 5.1%, P = .001), as did patients who did not meet any criteria but were nonetheless cultured (23.9% vs 8.5%, P < .001). Multiple logistic regression showed that all algorithm parameters were independently associated with outcome: ≥1+ anterior chamber cells (odds ratio [OR] 1.66, 95% confidence interval 1.09-2.52); ≥2 mm infiltrate (OR 4.74, 2.68-8.40); and ≤3 mm from corneal center (OR 2.82, 1.85-4.31), confirmed with comparison to a bootstrapped sample (n = 10,000). CONCLUSIONS: The implementation of this algorithm reduced vision-threatening complications for patients with lesions satisfying only 1 criterion, arguably the most difficult patients in whom to judge disease severity. Implementation also led to a decrease in patients receiving unnecessary care.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Ung L, Wang Y, Vangel M, et al. Validation of a Comprehensive Clinical Algorithm for the Assessment and Treatment of Microbial Keratitis. Am J Ophthalmol. 2019. PMID: 31899203. doi:10.1016/j.ajo.2019.12.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。